Evidence map›Paper›PMID 27065981›Full record

ArticleFrontiers in microbiology2016

Red Seaweeds Sarcodiotheca gaudichaudii and Chondrus crispus down Regulate Virulence Factors of Salmonella Enteritidis and Induce Immune Responses in Caenorhabditis elegans.

Garima Kulshreshtha, Tudor Borza, Bruce Rathgeber, Glenn S Stratton, Nikhil A Thomas, Alan Critchley, Jeff Hafting, Balakrishnan Prithiviraj

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
11.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. A PMAxxVeterinary sciences · 2022
    Article
  7. Review
  8. Advancement inBiosensors · 2021
    Review
  9. Molecules (Basel, Switzerland) · 2021
    Article
  10. Hydroethanolic Extracts ofBioMed research international · 2021
    Article
  11. Review
  12. Antimicrobial and Anti-Quorum Sensing Activities of Phlorotannins From Seaweed (Frontiers in cellular and infection microbiology · 2020
    Article
  13. Review
  14. Frontiers in cellular and infection microbiology · 2019
    Review
  15. Seaweed Extract (Stella MarisMarine drugs · 2018
    Article
  16. Article
  17. Feed Supplementation with Red Seaweeds,Frontiers in microbiology · 2017
    Article
  18. A Marine Actinomycete RescuesFrontiers in microbiology · 2017
    Article
  19. Beyond Traditional Antimicrobials: AFrontiers in microbiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Garima KulshreshthaDepartment of Environmental Sciences, Faculty of Agriculture, Dalhousie UniversityTruro, NS, Canada; Acadian Seaplants LimitedDartmouth, NS, Canada.
Tudor BorzaDepartment of Environmental Sciences, Faculty of Agriculture, Dalhousie University Truro, NS, Canada.
Bruce RathgeberDepartment of Plant and Animal Sciences, Faculty of Agriculture, Dalhousie University Truro, NS, Canada.
Glenn S StrattonDepartment of Environmental Sciences, Faculty of Agriculture, Dalhousie University Truro, NS, Canada.
Nikhil A ThomasDepartment of Microbiology and Immunology, Faculty of Medicine, Dalhousie University Halifax, NS, Canada.
Alan CritchleyAcadian Seaplants Limited Dartmouth, NS, Canada.
Jeff HaftingAcadian Seaplants Limited Dartmouth, NS, Canada.
Balakrishnan PrithivirajDepartment of Environmental Sciences, Faculty of Agriculture, Dalhousie University Truro, NS, Canada.
Dalhousie University · CAAcadian Seaplants (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red seaweeds are a rich source of unique bioactive compounds and secondary metabolites that are known to improve human and animal health. S. Enteritidis is a broad range host pathogen, which contaminates chicken and poultry products that end into the human food chain. Worldwide, Salmonella outbreaks have become an important economic and public health concern. Moreover, the development of resistance in Salmonella serovars toward multiple drugs highlights the need for alternative control strategies. This study evaluated the antimicrobial property of red seaweeds extracts against Salmonella Enteritidis using the Caenorhabditis elegans infection model. Six red seaweed species were tested for their antimicrobial activity against S. Enteritidis and two, Sarcodiotheca gaudichaudii (SG) and Chondrus crispus (CC), were found to exhibit such properties. Spread plate assay revealed that SG and CC (1%, w/v) significantly reduced the growth of S. Enteritidis. Seaweed water extracts (SWE) of SG and CC, at concentrations from 0.4 to 2 mg/ml, significantly reduced the growth of S. Enteritidis (log CFU 4.5-5.3 and log 5.7-6.0, respectively). However, methanolic extracts of CC and SG did not affect the growth of S. Enteritidis. Addition of SWE (0.2 mg/ml, CC and SG) significantly decreased biofilm formation and reduced the motility of S. Enteritidis. Quantitative real-time PCR analyses showed that SWE (CC and SG) suppressed the expression of quorum sensing gene sdiA and of Salmonella Pathogenesis Island-1 (SPI-1) associated genes sipA and invF, indicating that SWE might reduce the invasion of S. Enteritidis in the host by attenuating virulence factors. Furthermore, CC and SG water extracts significantly improved the survival of infected C. elegans by impairing the ability of S. Enteritidis to colonize the digestive tract of the nematode and by enhancing the expression of C. elegans immune responsive genes. As the innate immune response pathways of C. elegans and mammals show a high degree of conservation, these results suggest that these SWE may also impart beneficial effects on animal and human health.

Indexed as

Caenorhabditis elegansChondrus crispusimmune responseSalmonella enteritidisSarcodiotheca gaudichaudiivirulence factors

Identifiers

PMID27065981
PMCPMC4814495
OpenAlexW2328647516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.